Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [15047]

Probing the mechanism of ADAM28-mediated cancer metastasis

Probing the mechanism of ADAM28-mediated cancer metastasis

Kinase targets and anti-targets in cancer poly-pharmacology

Kinase targets and anti-targets in cancer poly-pharmacology

ASCO 2012: Blood test provides 'snapshot' of tumour drug response

ASCO 2012: Blood test provides 'snapshot' of tumour drug response

ASCO 2012: New MEK inhibitor, trametinib, improves survival in advanced melanoma

ASCO 2012: New MEK inhibitor, trametinib, improves survival in advanced melanoma

ASCO 2012: Afatinib delays progression of advanced lung adenocarcinomas, particularly in genetic subset of tumours

ASCO 2012: Afatinib delays progression of advanced lung adenocarcinomas, particularly in genetic subset of tumours

ASCO 2012: Newer, more costly drugs no better than standard weekly paclitaxel as first line therapy for locally advanced or metastatic breast cancer

ASCO 2012: Newer, more costly drugs no better than standard weekly paclitaxel as first line therapy for locally...

ASCO 2012: Lower levels of radiation therapy than previously thought can increase risk of breast cancer among young women treated for childhood cancer

ASCO 2012: Lower levels of radiation therapy than previously thought can increase risk of breast cancer among...

ATM and MET kinases are antagonists of p53-dependent apoptosis

ATM and MET kinases are antagonists of p53-dependent apoptosis

ASCO 2012: Lower-income patients less likely to participate in clinical trials

ASCO 2012: Lower-income patients less likely to participate in clinical trials

ASCO 2012: Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours, particularly those with chromosomal mutations

ASCO 2012: Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours...

More from ecancer